Newborn Calf Serum Market
- 2026 年市場規模
- USD 289.9 Mn
- 2033 年預估規模
- USD 459.4 Mn
- 年複合成長率 CAGR
- 6.8%
以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。
授權報價
| Single User Price | $4,500 USD |
| Enterprise License | $10,000 USD |
完整報告名稱與涵蓋範圍
Newborn Calf Serum Market, By Origin (New Zealand Origin, U.S. Origin, Australia Origin, Others (Brazil Origin, Mexico Origin, etc.)), By Application (Drug Discovery, Cell Media Culture), By End User (Biotechnology & Pharmaceutical Industries, Academic Institutes, Others (Research labs and Diagnostic Labs, etc.)), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
報告摘要
Newborn calf serum is the liquid portion of clotted blood taken from healthy, slaughtered bovine calves younger than 20 days that have been confirmed to be suitable for human consumption. It is widely used in industrial and academic research. It is one of the supplements used as a basal growth medium in cell culture. It plays a major role in stem cell research and the research of veterinary and human vaccines.
Fetal bovine serum and newborn calf serum both contain many of the same nutrients; however, newborn calf serum contains relatively more protein such as albumin and globulins. Bovine calves which are under 14 days old and healthy are inspected and collected for the production of newborn calf serum under strict collection and processing criteria. Newborn calf serum has applications in biotechnology research and development, stem cell research, cloning, animal diagnostic, in vitro fertilization, biopharmaceuticals, gene therapy, synthetic proteins, etc.
Market Dynamics
Increasing collaboration among the market players in order to expand their portfolio is expected to drive the growth of the global newborn calf serum market. For instance, in June 28, 2022, Terumo Blood and Cell Technologies, a medical technology company, collaborated with GenCure, a pharmaceutical company, to expand their manufacturing solutions for cell and gene therapy. The collaboration will utilize expertise from Terumo and GenCure to form a reference manufacturing center for BioBridge Global, provide a wide range of blood, cell and tissue products to customers worldwide. Through this reference site, GenCure will deliver solution for cell and gene therapy developers. Cell and gene therapy uses cell culture techniques and new born calf serum is used for growing different cell lines.
Market players are moving towards advance cell manufacturing technologies, which is expected to drive the global newborn calf serum market growth. For instance, in 2017, the Centre for Advanced Therapeutic Cell Technologies (CATCT) at MaRS, a nonprofit corporation found advanced manufacturing solutions to industrialize the cell manufacturing process to meet the needs of cell therapy companies around the world. Newborn calf serum is key ingredient in growing Vero cell lines, the development of cell manufacturing will increase the use of newborn calf serum.
Conferences have been organized and market players are participating on a large scale for discussion and talking about the rapid development in cell line and cell culture, which is expected to drive the global newborn calf serum market growth. For instance, in 2021, BioProcess International U.S. West conference held virtual event, highlighted its presentation on cell lines stability with different media, boom in cell-line development etc., they focused on increasing the awareness among market players about cell culture techniques, through which it is expected the use of calf serum will increase in market.
Key features of the study
• This report provides an in-depth analysis of the global newborn calf serum market, market size (US$ Million), and compound annual growth rate (CAGR %) for the forecast period (2022-2030), considering 2021 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players.
• It profiles leading players in the global newborn calf serum market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans.
• Key companies covered as a part of this study include HiMedia Laboratories, Thermo Fisher Scientific Inc., Sartorius AG, Merck KGaA, Corning Inc., Atlas Biologicals, Inc., TCS Biosciences Ltd., Bovogen Biologicals Pty Ltd., Novus Biologicals, LLC, Capricorn Scientific, PAN biotech, Atlanta Biologicals, Inc., Rockey Mountain Biologicals, GE Healthcare, Serana, and Zhejiang Tianhang Biotechnology.
• Insights from this report would allow marketers and management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics.
• The global newborn calf serum market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global newborn calf serum market
Market Segmentation
• Global Newborn Calf Serum Market, By Origin
o New Zealand Origin
o U.S. Origin
o Australia Origin
o Others (Brazil Origin, Mexico Origin, etc.)
• Global Newborn Calf Serum Market, By Application
o Drug Discovery
o Cell Media Culture
o Others
• Global Newborn Calf Serum Market, By End User
o Biotechnology & Pharmaceutical Industries
o Academic Institutes
o Others (Research labs and Diagnostic Labs, etc.)
• Global Newborn Calf Serum Market, By Region
o North America
U.S.
Canada
o Latin America
Brazil
Argentina
Mexico
Rest of Latin America
o Europe
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
o Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
o Middle East
GCC Countries
Israel
Rest of Middle East
o Africa
South Africa
North Africa
Central Africa
• Global Newborn Calf Serum Market, Key Player
o HiMedia Laboratories
o Thermo Fisher Scientific Inc.
o Sartorius AG
o Merck KGaA
o Corning Inc.
o Atlas Biologicals, Inc.
o TCS Biosciences Ltd.
o Bovogen Biologicals Pty Ltd.
o Novus Biologicals, LLC
o Capricorn Scientific
o PAN-Biotech GmbH
o Atlanta Biologicals, Inc.
o Rockey Mountain Biologicals
o GE Healthcare
o Serana
o Zhejiang Tianhang Biotechnology
目錄 Table of Contents
Table of Contents
1. Research Objectives and Assumptions
o Research Objectives
o Assumptions
o Abbreviations
2. Market Overview
o Report Description
Market Definition and Scope
o Executive Summary
Market Snippet, By Origin
Market Snippet, By Application
Market Snippet, By End User
Market Snippet, By Region
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
Drivers
Restraints
Market Opportunities
o Impact Analysis
o Regulatory Scenario
o PEST Analysis
o Recent Product Launch/Approval
o Epidemiology
o Mergers and Acquisitions
4. Global Newborn Calf Serum Market, By Origin, 2026-2033 (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 - 2033
Segment Trends
o New Zealand Origin
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
o U.S. Origin
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
o Australia origin
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
o Others (Brazil Origin, Mexico Origin, etc.)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
5. Global Newborn Calf Serum Market, By Application, 2026 - 2033 (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 - 2033
Segment Trends
o Drug Discovery
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
o Cell Media Culture
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
6. Global Newborn Calf Serum Market, By End Users, 2026 - 2033 (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 - 2033
Segment Trends
o Biotechnology and Pharmaceuticals industries
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
o Academics Institutes
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
o Other (Research labs and Diagnostic Labs, etc.)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
7. Global Newborn Calf Serum Market, By Region, 2026 - 2033 (USD Mn)
o Introduction
Market Share Analysis, By Region, 2026 and 2033 (%)
Y-o-Y Growth Analysis, For Regions, 2022 - 2033
Regional Trends
o North America
Market Size and Forecast, By Origin, 2026 - 2033 (USD Mn)
Market Size and Forecast, By Application, 2026 - 2033 (USD Mn)
Market Size and Forecast, By End User, 2026 - 2033 (USD Mn)
Market Size and Forecast, By Country, 2026 - 2033 (USD Mn)
o U.S.
o Canada
o Latin America
Market Size and Forecast, By Origin, 2026 - 2033 (USD Mn)
Market Size and Forecast, By Application, 2026 - 2033 (USD Mn)
Market Size and Forecast, By End User, 2026 - 2033 (USD Mn)
Market Size and Forecast, By Country, 2026 - 2033 (USD Mn)
o Brazil
o Mexico
o Argentina
o Rest of Latin America
o Europe
Market Size and Forecast, By Origin, 2026 - 2033 (USD Mn)
Market Size and Forecast, By Application, 2026 - 2033 (USD Mn)
Market Size and Forecast, By End User, 2026 - 2033 (USD Mn)
Market Size and Forecast, By Country, 2026 - 2033 (USD Mn)
o Germany
o U.K.
o France
o Italy
o Spain
o Russia
o Rest of Europe
o Asia Pacific
Market Size and Forecast, By Origin, 2026 - 2033 (USD Mn)
Market Size and Forecast, By Application, 2026 - 2033 (USD Mn)
Market Size and Forecast, By End User, 2026 - 2033 (USD Mn)
Market Size and Forecast, By Country, 2026 - 2033 (USD Mn)
o China
o India
o Japan
o Australia
o South Korea
o ASEAN
o Rest of Asia Pacific
o Middle East
Market Size and Forecast, By Origin, 2026 - 2033 (USD Mn)
Market Size and Forecast, By Application, 2026 - 2033 (USD Mn)
Market Size and Forecast, By End User, 2026 - 2033 (USD Mn)
Market Size and Forecast, By Country, 2026 - 2033 (USD Mn)
o GCC
o Israel
o Rest of Middle East
o Africa
Market Size and Forecast, By Origin, 2026 - 2033 (USD Mn)
Market Size and Forecast, By Application, 2026 - 2033 (USD Mn)
Market Size and Forecast, By End User, 2026 - 2033 (USD Mn)
Market Size and Forecast, By Country/Region , 2026 - 2033 (USD Mn)
o South Africa
o Central Africa
o North Africa
8. Competitive Landscape
o Company Profiles
HiMedia Laboratories
o Company Overview
o Drug Portfolio
o Financial Performance
o Recent Developments/Updates
o Strategies
Thermo Fisher Scientific Inc.
o Company Overview
o Drug Portfolio
o Financial Performance
o Recent Developments/Updates
o Strategies
Sartorius AG
o Company Overview
o Drug Portfolio
o Financial Performance
o Recent Developments/Updates
o Strategies
Merck KGaA.
o Company Overview
o Drug Portfolio
o Financial Performance
o Recent Developments/Updates
o Strategies
Corning Inc.
o Company Overview
o Drug Portfolio
o Financial Performance
o Recent Developments/Updates
o Strategies
Atlas Biologicals, Inc.
o Company Overview
o Drug Portfolio
o Financial Performance
o Recent Developments/Updates
o Strategies
TCS Biosciences Ltd.
o Company Overview
o Drug Portfolio
o Financial Performance
o Recent Developments/Updates
o Strategies
Bovogen Biologicals Tty Ltd.
o Company Overview
o Drug Portfolio
o Financial Performance
o Recent Developments/Updates
o Strategies
Novus Biologicals, LLC
o Company Overview
o Drug Portfolio
o Financial Performance
o Recent Developments/Updates
o Strategies
Capricorn Scientific
o Company Overview
o Drug Portfolio
o Financial Performance
o Recent Developments/Updates
o Strategies
PAN-Biotech GmbH
o Company Overview
o Drug Portfolio
o Financial Performance
o Recent Developments/Updates
o Strategies
Atlanta Biologicals, Inc.
o Company Overview
o Drug Portfolio
o Financial Performance
o Recent Developments/Updates
o Strategies
Rockey Mountain Biologicals
o Company Overview
o Drug Portfolio
o Financial Performance
o Recent Developments/Updates
o Strategies
GE Healthcare
o Company Overview
o Drug Portfolio
o Financial Performance
o Recent Developments/Updates
o Strategies
Serana
o Company Overview
o Drug Portfolio
o Financial Performance
o Recent Developments/Updates
o Strategies
Zhejiang Tianhang Biotechnology
o Company Overview
o Drug Portfolio
o Financial Performance
o Recent Developments/Updates
o Strategies
o Analyst Views
9. Section
o References
o Research Methodology
o About us and Sales Contact
提及公司
同分類最新報告（醫療與生命科學）
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們